Clinical Trial Update: Study of 18F-Thretide PET/CT in Patients With Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial assessing 18F-Thretide PET/CT imaging in patients with prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-Thretide (18F-Thretide)

Snippet

Sponsor: First Affiliated Hospital of Fujian Medical University | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED